Sarah Cannon Research Institute/Tennessee Oncology — Nashville, Tennessee

Sarah Cannon Research Institute/Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute/Tennessee Oncology has participated in 3 clinical trials.

Therapeutic areas: HER2-negative Metastatic Breast Cancer, HER2 Positive Solid Tumors, Neuroendocrine Tumors.

Sponsors: Dantari, Inc., Silverback Therapeutics, Tarveda Therapeutics.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute/Tennessee Oncology?

Sarah Cannon Research Institute/Tennessee Oncology has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute/Tennessee Oncology conducted?

Sarah Cannon Research Institute/Tennessee Oncology has 3 clinical trials on record. Their work covers HER2-negative Metastatic Breast Cancer, HER2 Positive Solid Tumors, Neuroendocrine Tumors.

Is Sarah Cannon Research Institute/Tennessee Oncology accredited by Crixeo Health?

Sarah Cannon Research Institute/Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute/Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.